Skip to main content
Log in

Praziquantel and albendazole in the combined treatment of experimental hydatid disease

  • ORIGINAL PAPER
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

The combination of praziquantel and albendazole (PZ + ABZ) used in the present study demonstrated an efficacy of 100% when used as chemoprophylactic treatment because no viable hydatid cysts developed after mice had been injected with protoscolices. However, when the PZ + ABZ combination was used for the treatment of 4-month secondary experimental hydatidosis, no significant difference was found between the control and treated mice, although severe damage to the cyst ultrastructure of the treated mice was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 17 June 2000 / Accepted: 14 September 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno, M., Urrea-París, M., Casado, N. et al. Praziquantel and albendazole in the combined treatment of experimental hydatid disease. Parasitol Res 87, 235–238 (2001). https://doi.org/10.1007/s004360000334

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004360000334

Keywords

Navigation